catheter

导管
  • 文章类型: Journal Article
    目的:直接抽吸首通技术(ADAPT)是一种有效且安全的血管内治疗远端中等血管闭塞(DMVOs)的方法。我们评估了用于急性缺血性中风患者M2闭塞的一线抽吸血栓切除术的新型再灌注导管(REDTM62)的技术特征和初步结果。适当的抽吸导管对于成功的ADAPT操作至关重要;然而,与用于大血管闭塞的导管相比,选择适用于较小血管的导管很少。
    方法:回顾性研究2022年12月至2024年2月期间,所有接受ADAPT治疗的患者均采用REDTM62作为急性M2闭塞的一线治疗方法。人口统计数据,程序时间和安全性,再通率,并记录结果数据.
    结果:20例患者的中位入院时间为美国国立卫生研究院卒中量表(NIHSS)评分为8分。在65.0%(13/20)的病例中,使用REDTM62进行了成功的血运重建(DMVO-脑梗死溶栓[TICI]≥2b)。首过效应为45.0%(9/20)。在两种情况下,REDTM62由于明显的远端血管弯曲而未到达凝块。在9例病例中额外使用了支架回收器,导致整体DMVO-TICI2c/3为90.0%(18/20)。平均手术时间为48分钟。未发生与ADAPT直接相关的并发症。住院死亡率为20.0%(4/20)。出院时NIHSS评分中位数为2.5分。55.0%(11/20)的病例在出院时获得了良好的功能结果(改良的Rankin量表0-2)。
    结论:我们使用新型REDTM62再灌注导管治疗M2闭塞的初步经验与已发表的数据一致。使用该导管的ADAPT可被视为安全有效的一线治疗选择。需要进一步的研究来验证初步结果。
    OBJECTIVE: The direct aspiration first pass technique (ADAPT) is an effective and safe endovascular treatment for distal medium vessel occlusions (DMVOs). We evaluated technical features and initial results of a novel reperfusion catheter (REDTM 62) used for frontline aspiration thrombectomy of M2 occlusions in acute ischemic stroke patients. Appropriate aspiration catheters are crucial for a successful ADAPT maneuver; however, the selection of catheters suitable for smaller-sized vessels is scarce compared to the ones for large vessel occlusions.
    METHODS: All patients treated with ADAPT using REDTM 62 as the frontline treatment approach for acute M2 occlusions between December 2022 and February 2024 were retrospectively enrolled. Demographic data, procedural timings and safety, recanalization rates, and outcome data were recorded.
    RESULTS: Twenty patients with a median admission National Institutes of Health Stroke Scale (NIHSS) score of 8 were identified. Successful revascularization (DMVO-thrombolysis in cerebral infarction [TICI]≥2b) with REDTM 62 aspiration thrombectomy was obtained in 65.0% (13/20) of cases. The first pass effect was 45.0% (9/20). In 2 cases, the REDTM 62 did not reach the clot due to marked distal vessel tortuosity. Stent retrievers were additionally used in 9 cases and led to an overall DMVO-TICI 2c/3 of 90.0% (18/20). Mean procedural time was 48 minutes. No complications directly related to ADAPT occurred. In-hospital mortality rate was 20.0% (4/20). The median discharge NIHSS score was 2.5. A good functional outcome at discharge (modified Rankin scale 0-2) was achieved in 55.0% (11/20) of cases.
    CONCLUSIONS: Our initial experiences with the novel REDTM 62 reperfusion catheter for treatment of M2 occlusions is in line with published data. ADAPT using this catheter may be considered as a safe and effective first-line treatment option. Further studies are warranted to validate the initial results.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在开发易于细菌定殖和生物膜形成的生物医学装置的惰性表面的抗感染涂层方面仍然存在挑战。这里,我们开发了一种简便的光固化方法来在惰性PDMS表面上构建功能化的聚合物涂层。使用带有百里酚基团的ATRP引发剂,将亲水性DMAEMA和含二苯甲酮的单体共聚形成具有末端官能团的聚合物。然后使用光固化反应在一个步骤中在惰性PDMS表面上构建末端官能化的杀生物涂层。功能化的PDMS表面表现出优异的抗菌和防污性能,能够在大约6小时内完全消除MRSA,并有效抑制生物膜的生长。此外,在0.9%生理盐水和尿液等体液环境中具有良好的稳定性和持久的抗菌活性。根据膀胱模型实验,通过抑制细菌沿着导管内表面的生长和迁移,导管的寿命可以从大约7天延长到35天。因此,光固化技术在惰性生物医学装置的表面官能化方面是非常有前途的,以便最小化感染的扩散。本文受版权保护。保留所有权利。
    A challenge remains in the development of anti-infectious coatings for the inert surfaces of biomedical devices that are prone to bacterial colonization and biofilm formation. Here, a facile photocuring method to construct functionalized polymeric coatings on inert polydimethylsiloxane (PDMS) surfaces, is developed. Using atom transfer radical polymerization (ATRP) initiator bearing thymol group, hydrophilic DMAEMA and benzophenone (BP)-containing monomers are copolymerized to form polymers with end functional groups. An end-functionalized biocidal coating is then constructed on the inert PDMS surface in one step using a photocuring reaction. The functionalized PDMS surfaces show excellent antibacterial and antifouling properties, are capable of completely eradiating MRSA within ≈6 h, and effectively inhibit the growth of biofilms. In addition, they have good stability and long-lasting antibacterial activity in body fluid environments such as 0.9% saline and urine. According to bladder model experiments, the catheter\'s lifespan can be extended from ≈7 to 35 days by inhibiting the growth and migration of bacteria along its inner surface. The photocuring technique is therefore very promising in terms of surface functionalization of inert biomedical devices in order to minimize the spread of infection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:隧道式中心静脉导管通常用于没有功能性永久性血管通路的患者的透析。在紧急情况下,一个非隧道,临时中心静脉导管通常用于立即透析。导管插入最关键的步骤是静脉穿刺,这通常是延长干预时间和与手术相关的不良事件的主要原因。为避免在放置更永久的隧道导管时发生此关键步骤,可以考虑对以前放置的临时交换。在本文中,我们提出了一种具有单独访问站点的改进的交换方法。方法:在对前瞻性数据库的回顾性分析中,我们检查了这种改进的技术是否不劣于从头应用。因此,我们纳入了2018年3月至2023年3月在我们的研究中心接受首根隧道式透析导管的所有396例患者.在这些中,143例患者接受了改良方法,253例接受了标准的从头超声引导穿刺和插入。然后,两组的结果,包括不良事件和感染,通过非参数检验和多变量逻辑回归进行比较。结果:两组,种植100%成功。根据CDC标准,18例因感染而进行导管外植术是必要的,两组之间没有差异(5.0%vs.4.4%p=0.80)。每100天的感染率为0.113。对照组为0.106,具有可比的细菌谱。总共12根导管(3根与9)由于介入周围的并发症而不得不移除。早期感染是研究组2例(1.3%)和对照组5例(1.9%)的原因。仅在对照组中有2例发生导管完全错位。通过多变量逻辑回归校正潜在的混杂因素后,并发症发生率没有显着差异(校正后的比值比,aOR=0.53,95%CI=0.14-2.03,p=0.351),但基于平均治疗效果-1.7%的总体估计风险降低,有利于研究组。结论:本研究表明,导管交换不会导致比从头放置更多的感染;因此,这是一个可行的方法。此外,通过交换完全避免了静脉穿刺后排除气胸的置换和对照胸部X线检查。这种方法产生的感染率比以前的报告低得多:1.3%,而在所有现有的汇总研究中为2.7%。所提出的方法似乎优于现有的切换方法。总的来说,交换也可以帮助保存静脉以备将来使用,因为使用相同的颈静脉。
    Background: Tunneled central venous catheters are commonly used for dialysis in patients without a functional permanent vascular access. In an emergent setting, a non-tunneled, temporary central venous catheter is often placed for immediate dialysis. The most critical step in the catheter insertion is venipuncture, which is often a major cause for longer intervention times and procedure-related adverse events. To avoid this critical step when placing a more permanent tunneled catheter, an exchange over a previously placed temporary one can be considered. In this paper, we present a modified switching approach with a separate access site. Methods: In this retrospective analysis of a prospective database, we examined whether this modified technique is non-inferior to a de novo application. Therefore, we included all 396 patients who received their first tunneled dialysis catheter at our site from March 2018 to March 2023. Out of these, 143 patients received the modified approach and 253 the standard de novo ultrasound-guided puncture and insertion. Then, the outcomes of the two groups, including adverse events and infections, were compared by nonparametric tests and multivariable logistic regression. Results: In both groups, the implantations were 100% successful. Catheter explantation due to infection according to CDC criteria was necessary in 18 cases, with no difference between the groups (5.0% vs. 4.4% p = 0.80). The infection rate per 100 days was 0.113 vs. 0.106 in the control group, with a comparable spectrum of bacteria. A total of 12 catheters (3 vs. 9) had to be removed due to a periinterventional complication. An early-onset infection was the reason in two cases (1.3%) in the study group and five in the control group (1.9%). A total misplacement of the catheter occurred in two cases only in the control group. After adjustment for potential confounders via multivariable logistic regression there was not a significant difference in the complication rate (adjusted odds ratio, aOR = 0.53, 95% CI = 0.14-2.03, p = 0.351) but an estimated decreased risk overall based on the average treatment effect of -1.7% in favor of the study group. Conclusions: The present study shows that a catheter exchange leads to no more infections than a de novo placement; hence, it is a feasible method. Moreover, misplacements and control chest X-rays to exclude pneumothorax after venipuncture were completely avoided by exchanging. This approach yields a much lower infection rate than previous reports: 1.3% compared to 2.7% in all existing aggregated studies. The presented approach seems to be superior to existing switching methods. Overall, an exchange can also help to preserve veins for future access, since the same jugular vein is used.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:尿路感染是最常见的医院获得性感染,80%与导管插入有关。诊断方法可能会影响这些病原体的报告身份,实验室条件下的表型检测可能无法反映感染表型。这项研究旨在通过表征英国医院的导管相关尿路感染分离株,评估诊断方法的有效性以及培养基成分是否改变表型。
    结果:我们比较了五种细菌鉴定方法,包括生化检测,MALDI生物分型,和基因组测序,发现属或种水平识别的差异。表型测定和基因组预测之间的抗生素敏感性比较仅在多药耐药菌株中显示高度一致。为了确定生长速率和生物膜形成是否受培养基组成的影响,菌株在浮游和生物膜状态下生长。与丰富的实验室培养基相比,在人工尿液中观察到低浮游生长和显着的生物膜形成,强调分析设计的重要性。
    结论:这项研究强调了依赖单一诊断方法进行物种鉴定的风险,提倡全基因组测序的准确性。它强调了表型方法在了解临床环境中的抗生素耐药性方面的持续重要性,以及对反映体内病原体遇到的表征条件的需求。
    OBJECTIVE: Urinary tract infections are the most common hospital-acquired infection, 80% are associated with catheterisation. Diagnostic methods may influence the reported identities of these pathogens, and phenotypic testing under laboratory conditions may not reflect infection phenotypes. This study aimed to evaluate the efficacy of diagnostic methods and whether medium composition alters phenotypes by characterizing catheter-associated urinary tract infection isolates from a UK hospital.
    RESULTS: We compared five bacterial identification methods, including biochemical testing, MALDI biotyping, and genome sequencing, finding differences in genus or species level identifications. Antibiotic susceptibility comparisons between phenotypic assays and genomic predictions showed high agreement only in multidrug-resistant strains. To determine whether growth rate and biofilm formation were affected by medium composition, strains were grown in both planktonic and biofilm states. Low planktonic growth and significant biofilm formation were observed in artificial urine compared to rich laboratory media, underscoring the importance of assay design.
    CONCLUSIONS: This study highlights the risks of relying on a single diagnostic method for species identification, advocating for whole-genome sequencing for accuracy. It emphasizes the continued importance of phenotypic methods in understanding antibiotic resistance in clinical settings and the need for characterization conditions that mirror those encountered by pathogens in the body.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:大肠杆菌通常在特定人群中引起导管相关性血流感染(C-RBSI)。阳性差分时间(DTTP)技术是诊断C-RBSI的推荐保守程序。
    方法:我们对使用DTTP技术从导管腔中分离出大肠杆菌的事件进行了回顾性研究。根据DTTP技术获得的微生物和临床数据作为导管定植,C-RBSI,或非C-RBSI。
    结果:共包括89个导管血培养,分类如下:导管定植,33.7%;C-RBSI,9.0%;和非C-RBSI,57.3%。只有15.7%的导管被撤回,导管尖端无阳性培养。我们发现导管类型没有统计学上的显著差异,抗生素治疗,或组中的临床结果,导管锁定治疗的频率或成功治疗的频率除外。只有一名患者的死亡率与C-RBSI相关。
    结论:E.在大多数患者中,通过DTTP技术诊断的大肠杆菌菌血症被归类为非导管相关性.由于保留了大部分导管,通过导管尖端培养,无法在微生物学上确认大肠杆菌菌血症与导管相关。需要未来的研究来评估DTTP技术诊断大肠杆菌C-RBSI的盈利能力。
    BACKGROUND: Escherichia coli commonly causes catheter-related bloodstream infection (C-RBSI) in specific populations. The differential time to positivity (DTTP) technique is the recommended conservative procedure for diagnosing C-RBSIs.
    METHODS: We conducted a retrospective study of episodes in which E. coli was isolated from catheter lumens obtained using the DTTP technique. Microbiological and clinical data were obtained based on the DTTP technique as either catheter colonization, C-RBSI, or non-C-RBSI.
    RESULTS: A total of 89 catheter blood cultures were included, classified as follows: catheter colonization, 33.7%; C-RBSI, 9.0%; and non-C-RBSI, 57.3%. Only 15.7% of the catheters were withdrawn, with no positive catheter-tip cultures. We found no statistically significant differences in catheter type, antibiotic treatment, or clinical outcome among the groups, except for the frequency of catheter lock therapy or in the frequency of successful treatment. Mortality was associated with C-RBSI in only one patient.
    CONCLUSIONS: E. coli bacteremia diagnosed by the DTTP technique was classified as non-catheter-related in most patients. As the majority of the catheters were retained, E. coli bacteremia could not be microbiologically confirmed as catheter-related by the catheter-tip culture. Future studies are needed to assess the profitability of the DTTP technique for diagnosing E. coli C-RBSIs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    导管相关尿路感染是最常见的医院获得性感染,会导致患者不适。发病率增加,和长时间停留,给医疗服务带来了巨大的负担。在插入时发生定植,或者后来从丰富的尿道周围菌群中上升微生物,因此,医疗程序实际上是不可避免的。重要的是,停留时间是细菌尿症的重要危险因素,因为它使生物膜有时间发育和成熟。这就是为什么我们通过超声波和纳米粒子辅助自组装在有机硅表面上设计抗菌和抗生物膜涂层,并在体外和体内对其进行彻底验证。为此,我们结合了双金属银/金纳米颗粒,既发挥杀生物作用又发挥结构作用,多巴胺改性明胶在一个容易的和不依赖底物的声化学涂层过程。后者启发贻贝的生物粘附力增强了涂层的活性和耐久性,同时减弱了银的固有毒性。因此,我们的方法有效地减少了人膀胱的流体动力学模型中的生物膜形成,并防止了在放置一周的导管兔的细菌尿,优于传统的硅胶导管。这些结果证实了纳米颗粒-生物聚合物复合材料与超声结合用于留置医疗设备的抗微生物功能化的实际用途。
    Catheter-associated urinary tract infections are the most common hospital-acquired infections and cause patient discomfort, increased morbidity, and prolonged stays, altogether posing a huge burden on healthcare services. Colonization occurs upon insertion, or later by ascending microbes from the rich periurethral flora, and is therefore virtually unavoidable by medical procedures. Importantly, the dwell time is a significant risk factor for bacteriuria because it gives biofilms time to develop and mature. This is why we engineer antibacterial and antibiofilm coating through ultrasound- and nanoparticle-assisted self-assembly on silicone surfaces and validate it thoroughly in vitro and in vivo. To this end, we combine bimetallic silver/gold nanoparticles, which exercise both biocidal and structural roles, with dopamine-modified gelatin in a facile and substrate-independent sonochemical coating process. The latter mussel-inspired bioadhesive potentiates the activity and durability of the coating while attenuating the intrinsic toxicity of silver. As a result, our approach effectively reduces biofilm formation in a hydrodynamic model of the human bladder and prevents bacteriuria in catheterized rabbits during a week of placement, outperforming conventional silicone catheters. These results substantiate the practical use of nanoparticle-biopolymer composites in combination with ultrasound for the antimicrobial functionalization of indwelling medical devices.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在急性胰腺炎(AP)患者中,壁坏死(WON)双模式引流的作用已确立。然而,没有关于临床结局与经皮导管引流(PCD)时机的相关性的数据.我们调查了WON内镜引流后PCD的时机对AP临床结局的影响。材料与方法这项回顾性研究包括2018年9月至2023年3月期间接受了WON内镜下膀胱胃造口术(CG),随后接受PCD的坏死性AP患者。根据内窥镜CG到PCD间隔,患者被分为两组(≤和>3天,≤和>1周,≤和>10天,且≤且>2周)。记录CG和PCD的基线特征和适应症。比较两组之间的临床结果,包括住院时间,重症监护病房住院时间,需要手术坏死切除术,住院期间死亡。结果30例患者(平均年龄±标准差,评估了35.5±12.7年)。平均CG至PCD间隔为11.2±7.5天。两组之间的基线特征以及CG和PCD的适应症没有显着差异。两组之间的平均疼痛至CG间隔没有显着差异。在10天后(p=0.003)和2周后(p=0.032)接受CG的患者中,进行了内窥镜坏死切除术的比例明显更高。两组间并发症和临床结局无显著差异。结论内镜下CG术后PCD的时机不影响临床结局。
    Background  The role of dual-modality drainage of walled-off necrosis (WON) in patients with acute pancreatitis (AP) is established. However, there are no data on the association of clinical outcomes with the timing of percutaneous catheter drainage (PCD). We investigated the impact of the timing of PCD following endoscopic drainage of WON on clinical outcomes in AP. Materials and Methods  This retrospective study comprised consecutive patients with necrotizing AP who underwent endoscopic cystogastrostomy (CG) of WON followed by PCD between September 2018 and March 2023. Based on endoscopic CG to PCD interval, patients were divided into groups (≤ and >3 days, ≤ and >1 week, ≤ and >10 days, and ≤ and >2 weeks). Baseline characteristics and indications of CG and PCD were recorded. Clinical outcomes were compared between the groups, including length of hospitalization, length of intensive care unit stay, need for surgical necrosectomy, and death during hospitalization. Results  Thirty patients (mean age ± standard deviation, 35.5 ± 12.7 years) were evaluated. The mean CG to PCD interval was 11.2 ± 7.5 days. There were no significant differences in baseline characteristics and indications of CG and PCD between the groups. The mean pain to CG interval was not significantly different between the groups. Endoscopic necrosectomy was performed in a significantly greater proportion of patients undergoing CG after 10 days ( p  = 0.003) and after 2 weeks ( p  = 0.032). There were no significant differences in the complications and clinical outcomes between the groups. Conclusion  The timing of PCD following endoscopic CG does not affect clinical outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    我们回顾了在串联闭塞的情况下尝试近端血栓切除术后颈动脉内膜切除术(CEA)和直接颈动脉进入远端血栓切除术的技术。一名70多岁的患者出现右面部下垂和流口水,发现左颈动脉严重狭窄,左颈内动脉海绵样段充盈缺损,符合血管闭塞。脑梗死(TICI)0和左M2大脑中动脉(MCA)闭塞的溶栓治疗。在颈动脉球内注射微导管引导下多次尝试不同的导线形状,我们无法穿过闭塞。选择通过远端血栓切除术转换为开放式CEA。动脉切开术关闭后,在开放手术区域内使用5Fr桡动脉鞘直接进入颈动脉以进行远端血栓切除术。将5Fr抽吸导管导航至左侧M2MCA,然后重新捕获支架取出器并实现TICI2B再灌注。
    We review the technique for carotid endarterectomy (CEA) and direct carotid access for distal thrombectomy after attempted proximal thrombectomy in the setting of tandem occlusions. A patient in their 70s presented with right facial droop and drooling and was found to have critical left carotid stenosis with filling defect in the cavernous segment of the left internal carotid artery consistent with vessel occlusion, Thrombolysis in Cerebral Infarction (TICI) 0, and left M2 middle cerebral artery (MCA) occlusion. After multiple attempts with different wire shapes guided by microcatheter injections within the carotid bulb, we were unable to cross the occlusion. Conversion to open CEA with distal thrombectomy was elected. Following closure of the arteriotomy, direct carotid access using a 5Fr radial artery sheath was achieved within the open surgical field for distal thrombectomy. A 5Fr aspiration catheter was navigated to the left M2 MCA where a stent retriever was then recaptured and TICI 2B reperfusion was achieved.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:机械血栓切除术(MT)是中风治疗护理标准的一部分,提高其疗效是临床研究的主要目标之一。重要的是放置球囊引导导管(BGC)的远端。我们的目标是确定这是否会影响结果。
    方法:我们分析了来自ASSIST注册中心的数据,一个国际,1492例患者的多中心前瞻性研究。我们根据BGC的放置将接受BGC治疗的患者分为:宫颈低位(LCG(颈内动脉(ICA)的下2/3)或宫颈高位(HCG(宫颈ICA的上1/3,Petro-lacerum或更高))。我们分析了主要MT技术的总体特征和结果,并对其进行了分层:仅支架式检索器(SRClassic),联合使用抽吸导管和SR(联合),和直接抽吸(ADAPT)。
    结果:我们的研究包括704名受试者,低宫颈组-323名,高宫颈组-381名。女性和串联病变的比例存在统计学差异(LCG均较高)。在手术结束时(P<0.0001)和较短的手术(P=0.0005),将BGC置于高颈段与较好的再通率(扩大的脑梗死(eTICI)评分为2c-3)相关。在对三种主要技术(SRClassic,合并,和适应),将BGC放在高段与更好的首传效果(FPE)相关,远端栓塞较少,和更好的临床结果在SR经典技术。
    结论:将BGC的远端置于宫颈高段或更高段与更好的再通相关。
    BACKGROUND: Mechanical thrombectomy (MT) is part of the standard of care for stroke treatment, and improving its efficacy is one of the main objectives of clinical investigation. Of importance is placement of the distal end of balloon-guided catheters (BGC). We aim to determine if this influences outcomes.
    METHODS: We analyzed data from the ASSIST Registry, an international, multicenter prospective study of 1492 patients. We divided patients treated with BGC according to the placement of the BGC: low cervical (LCG (the lower 2/3 of cervical internal carotid artery (ICA)) or high cervical (HCG (upper 1/3 of cervical ICA, petro-lacerum or higher)). We analyzed characteristics and outcomes overall and stratified on the primary MT technique: Stent-Retriever only (SR Classic), Combined use of aspiration catheter and SR (Combined), and Direct Aspiration (ADAPT).
    RESULTS: Our study included 704 subjects -323 in the low cervical and 381 in the high cervical groups. Statistical differences were seen in the proportion of females and tandem lesions (both higher for LCG). Placing the BGC in the high cervical segment is associated with better recanalization rates (expanded treatment in cerebral infarction (eTICI) score of 2c-3) at the end of the procedure (P<0.0001) and shorter procedures (P=0.0005). After stratifying on the three primary techniques (SR Classic, Combined, and ADAPT), placing the BGC in the high segment is associated with a better first-pass effect (FPE), less distal emboli, and better clinical outcomes in the SR Classic technique.
    CONCLUSIONS: Placing the distal end of the BGC at the high cervical segment or higher is associated with better recanalization.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    由于细菌的粘附,在留置医疗装置(例如导管和呼吸机)上形成生物膜对医疗保健提出了重大挑战。具有微米和纳米结构的表面改性提供了防止生物粘附的有前途的策略,并且比表面化学改性方法更安全。这里,使用丝素蛋白(SF)水凝胶和输注模塑方法制备导管,内表面具有受荷叶启发的微乳头结构(SF-CMP)。苯乙醇(PEA)熏蒸处理后,与甲醇处理的导管(SF-CMPMeOH)相比,所得导管(SF-CMPPEA)显示出改善的耐溶胀性和机械性能。PEA在控制大小方面比甲醇更有效,分布,和丝结晶β片块的含量,从而溶胀和机械性能。此外,SF-CMPPEA上的微乳头结构在溶液中保持稳定超过35天,与SF-CMPMeOH相比,持续<7天。SF-CMPPEA在体外表现出对大肠杆菌和金黄色葡萄球菌的驱除作用,并且对在未图案化表面上培养的内皮细胞具有低细胞毒性。此外,皮下植入研究表明,与对照组相比,微图案化样品周围的炎症减少,未图案化的表面。SF基材料的独特性能,包括可调结构,生物相容性,降解,和药物负载能力使它们成为从留置医疗设备到组织工程支架等应用中抗生物粘附的有吸引力的材料。
    Biofilm formation on indwelling medical devices such as catheters and ventilators due to the adhesion of bacteria poses significant challenges in healthcare. Surface modification with micro- and nano-structures offers a promising strategy to prevent bioadhesion and is safer than surface chemical modification approaches. Here, catheters were prepared using silk fibroin (SF) hydrogels and an infusion molding method, with the inner surface featuring a micropapillae structure inspired by lotus leaves (SF-CMP). After phenylethanol (PEA) fumigation treatment, the resulting catheters (SF-CMP PEA) displayed improved swelling resistance and mechanical properties compared to methanol-treated catheters (SF-CMP MeOH). PEA was more efficient than methanol in controlling the size, distribution, and content of silk crystalline β-sheet blocks and thus the swelling and mechanical properties. Moreover, the micro-papillae structure on SF-CMP PEA remained stable over 35 days in solution, in contrast to SF-CMP MeOH, which lasted <7 days. SF-CMP PEA exhibited repellent effects against E. coli and S. aureusin vitro, and low cytotoxicity to the endothelial cells cultured on the unpatterned surface. Additionally, subcutaneous implantation studies showed reduced inflammation around the micropatterned samples compared to controls with a plain, unpatterned surface. The unique properties of SF-based materials, including tunable structures, biocompatibility, degradation, and drug-loading capability make them an attractive material for anti-bioadhesion in applications ranging from indwelling medical devices to tissue engineering scaffolds.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号